Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma

doi:10.3748/wjg.14.4739

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3228)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

265

HTML

2576

Figures (1-3)

176

Tables (1-1)

211

Sum=3228

Aug 14, 2008 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Aug 14, 2008; 14(30): 4739-4744
Published online Aug 14, 2008. doi: 10.3748/wjg.14.4739

Open in New Tab Full Size Figure Download Figure

Figure 1 Immunohistochemical staining for NF-κB-p65 showing p65 expression in cancer tissue samples but not in adjacent non-neoplastic tissue samples (SABC, × 100) (A), in gastric adenocarcinoma epithelial tissue samples (SABC, × 200) (B), in intestinal metaplasia samples (SABC, × 200) (C), in nuclei of cancer cells (SABC, × 200) (D), and very weak expression of NF-κB-p65 in gastric mucosa samples (SABC, × 200) (E), and in negative control (SABC, × 200) (F).

Open in New Tab Full Size Figure Download Figure

Figure 2 Images of EMSA. Lanes 1-3: NF-κB activity in normal, moderately- and poorly- differentiated gastric carcinoma tissue samples.

Open in New Tab Full Size Figure Download Figure

Figure 3 Survival cures for OS time of patients after treatment with PLF and FOLFOX.

Citation: Ye S, Long YM, Rong J, Xie WR. Nuclear factor kappa B: A marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol 2008; 14(30): 4739-4744
URL: https://www.wjgnet.com/1007-9327/full/v14/i30/4739.htm
DOI: https://dx.doi.org/10.3748/wjg.14.4739